Key facts
- Notable investors include Nantong Zijing Capital, Nantong Industries Holding Group.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Sanshubio
- ·The full record, as it builds
Funding rounds
No funding rounds for Sanshubio are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Sanshubio
Provider of biological research testing services for research institutions and enterprises. The company is committed to professional scientific research and technical services, covering medicine, botany, agronomy, Chinese medicinal materials, environment, soil, plant-based new materials, etc., providing clients with functional polysaccharide analysis, starch structure analysis, high-throughput sequencing, proteomics and metabolomics services.
- Sector
- Business Products and Services (B2B)
- HQ
- Nantong, China
- Founded
- 2013
- Employees
- 200
- Website
- sanshubio.com/
- Ownership
- Privately Held (backing)
Sanshubio doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Sanshubio shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Sanshubio in its N-PORT filings yet. We sweep new filings monthly.